5 Mad Money Stock Picks This Week

In this article, we will take a look at the 5 Mad Money stock picks this week. To see more such companies, go directly to 10 Mad Money Stock Picks This Week.

5. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 76

Jim Cramer gave positive comments about Eli Lilly and Company (NYSE:LLY) in a Lightning Round of his program earlier this month. Cramer said that he is going to buy some more of Eli Lilly and Company (NYSE:LLY) stock for his charitable trust.

Recently, the US FDA granted an additional indication for Eli Lilly and Company (NYSE:LLY) Verzenio (abemaciclib) in combination with endocrine therapy as an adjuvant treatment for HR+, HER2- node-positive, early breast cancer at high risk of occurrence.

At the end of the fourth quarter of 2022, 76 hedge funds out of the 943 funds reported owning stakes in Eli Lilly and Company (NYSE:LLY). The total value of these stakes was about $5.2 billion. The most notable stakeholder of Eli Lilly and Company (NYSE:LLY) was Rajiv Jain’s GQG Partners which owns a $603 million stake in the company.

Baron Funds made the following comment about Eli Lilly and Company (NYSE:LLY) in its Q4 2022 investor letter:

“Eli Lilly and Company (NYSE:LLY) is a large-cap pharmaceutical company. Shares increased on investor optimism about Lilly’s new product pipeline, which includes Mounjaro for diabetes and obesity and Donanemab for Alzheimer’s disease. We continue to think Lilly has a healthy base business with limited near-term patent expirations, a strong pipeline, and potential for significant margin expansion, which should translate to strong revenue and earnings growth over at least the next five years.”